Carol Moore

Part of Oneblood Foundation, Inc., OBF Investments LLC provides investment services. The company is based in St. Petersburg, FL.

The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

Prothya Biosolutions Belgium BV is a Belgian company that was founded in 1997. The private company is based in Brussels, Belgium. The company manufactures plasma and pharmaceutical raw materials and operate as blood transfusion centers and organ banks.

1858 Capital Partners LLC is a boutique M&A advisory firm that specializes in mergers and acquisitions and principal investments. The private company is based in Winter Park, FL, and has subsidiaries in the United States. The company has a focus on the middle market and utilizes its network, internal resources, and the latest technology to attain successful transactions. Unlike traditional investment banks, 1858 was formed with a community banking model in mind. The 1858 team is very selective regarding engagements and looks to limit the number of engagements taken on at any one time so maximum client interfacing is achieved. The company was founded in 2022 by Jay Chaudhari, Michael Skat, Michael Ward, Michael A. Okaty.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

Part of Sanquin Blood Supply Foundation, Sanquin Plasma Products BV acts as a private group led by Biosolutions LLC and Fortissimo Capital Management Lt. The company is based in Amsterdam, Netherlands. The CEO of the Dutch company is Tjark Tjin-A-Tsoi.

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.

OneBlood, Inc. operates blood centers. It serves Florida and areas of South Carolina, Georgia and Alabama, and Community Blood Center of the Carolinas. The company is headquartered in St. Petersburg, FL.

Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland.

CellChorus LLC is a company that applies artificial intelligence to visually evaluate the performance of individual immune cells such as T cells and NK cells over time. The company is based in South San Francisco, CA and was founded by Navin Varadarajan and Laurence James Neil Cooper. The company uses time-lapse imaging microscopy in nanowell grids (TIMING) with neural network-based AI to identify cells and evaluate their activity. The company's patent-protected platform can link TIMING data and insights with information from other analysis modalities to provide a comprehensive understanding of cellular function, state, and phenotype for the life sciences industry. CellChorus conducts dynamic single-cell analysis at scale and has been featured in various publications such as Blood, Leukemia, and Nature Immunology. Daniel Meyer has been the CEO of the company since 2020.